Literature DB >> 4799141

Combination chemotherapy: the antagonism of methotrexate and cytosine arabinoside.

M H Tattersall, K R Harrap.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4799141     DOI： 10.1016/s0014-2964(73)80023-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  7 in total

1.  Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.

Authors:  N K Ayisi; V S Gupta; J B Meldrum; A K Taneja; L A Babiuk
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

2.  Biochemical interactions between methotrexate and 1-beta-D-arabinofuranosylcytosine in hematopoietic cells of children: a Pediatric Oncology Group study.

Authors:  E M Newman; D G Villacorte; A M Testi; R A Krance; M B Harris; Y Ravindranath; D Pinkel
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.

Authors:  E Cadman; F Eiferman
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

4.  Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.

Authors:  Yousif Matloub; Susan Lindemulder; Paul S Gaynon; Harland Sather; Mei La; Emmett Broxson; Rochelle Yanofsky; Raymond Hutchinson; Nyla A Heerema; James Nachman; Marilyn Blake; Linda M Wells; April D Sorrell; Margaret Masterson; John F Kelleher; Linda C Stork
Journal:  Blood       Date:  2006-04-11       Impact factor: 22.113

5.  Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin.

Authors:  J J Kirsi; P A McKernan; N J Burns; J A North; B K Murray; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

6.  Red blood cell hypoxanthine phosphoribosyltransferase activity measured using 6-mercaptopurine as a substrate: a population study in children with acute lymphoblastic leukaemia.

Authors:  L Lennard; J P Hale; J S Lilleyman
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

7.  Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir.

Authors:  Solenne Vigne; Sophie Duraffour; Graciela Andrei; Robert Snoeck; Daniel Garin; Jean-Marc Crance
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.